Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients
Not Applicable
- Conditions
- HBV CoinfectionHIV Infections
- Interventions
- Drug: efavirenz+tenofovir+lamivudine
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2011-03-18
- Lead Sponsor
- Yunnan AIDS Care Center
- Target Recruit Count
- 60
- Registration Number
- NCT01318096
- Locations
- 🇨🇳
Yunnan Provincial Hospital of Infectious Diseases/Yunnan AIDS Care Center, Kunming, Yunnan Provice, China
© Copyright 2025. All Rights Reserved by MedPath